Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Warehouse Reit backs Blackstone in £489m takeover battle

(Sharecast News) - Blackstone Europe took a step closer to securing Warehouse Reit on Friday, after the London-listed property group backed an improved £489m takeover bid. Warehouse, a specialist in industrial real estate, had originally recommended a £485.2m offer from fellow landlord Tritax Big Box, having rejected Blackstone's first approach in June.

However, on Thursday the US private equity firm upped its offer to 113.4p per share, alongside a dividend of 1.3p per share, valuing the business at £489m.

That beat Tritax's cash and shares offer, and on Friday Warehouse withdrew its backing.

Neil Kirton, Warehouse chair, said the firm's independent directors had "carefully evaluated" both offers.

He continued: "The increased Blackstone offer provides Warehouse shareholders with a certain all-cash offer, at a premium to the Tritax offer, which comprises a mixed consideration of new Tritax shares and cash, and the independent directors now switch their recommendation in favour of the increase Blackstone offer accordingly."

Blackstone originally said its initial 109p approach was its best and final offer. But it reserved the right to increase the price should another party express interest in the business.

As at 0930 BST, shares in Warehouse were largely unchanged at 115.28p, while Tritax was down 1% at 142.3p.

Tritax, which specialises in supply chain infrastructure, has yet to comment.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.